Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection
Ismael P. Sauter, … , Wadih Arap, Mauro Cortez
Ismael P. Sauter, … , Wadih Arap, Mauro Cortez
Published May 16, 2019
Citation Information: JCI Insight. 2019;4(10):e126207. https://doi.org/10.1172/jci.insight.126207.
View: Text | PDF
Research Article Infectious disease

TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection

  • Text
  • PDF
Abstract

Virulent protozoans named Leishmania in tropical and subtropical areas produce devastating diseases by exploiting host immune responses. Amastigotes of Leishmania amazonensis stimulate macrophages to express CD200, an immunomodulatory ligand, which binds to its cognate receptor (CD200R) and inhibits the inducible nitric oxide synthase and nitric oxide (iNOS/NO) signaling pathways, thereby promoting intracellular survival. However, the mechanisms underlying CD200 induction in macrophages remain largely unknown. Here, we show that phagocytosis-mediated internalization of L. amazonensis amastigotes following activation of endosomal TLR9/MyD88/TRIF signaling is critical for inducing CD200 in infected macrophages. We also demonstrate that Leishmania microvesicles containing DNA fragments activate TLR9-dependent CD200 expression, which inhibits the iNOS/NO pathway and modulates the course of L. amazonensis infection in vivo. These findings demonstrate that Leishmania exploits TLR-signaling pathways not only to inhibit macrophage microbicidal function, but also to evade host systemic immune responses, which has many implications in the severity of the disease.

Authors

Ismael P. Sauter, Katerine G. Madrid, Josiane B. de Assis, Anderson Sá-Nunes, Ana C. Torrecilhas, Daniela I. Staquicini, Renata Pasqualini, Wadih Arap, Mauro Cortez

×

Figure 4

Leishmaniaamazonensis amastigotes release DNA-containing EVs for CD200 induction.

Options: View larger image (or click on image) Download as PowerPoint

Leishmaniaamazonensis amastigotes release DNA-containing EVs for CD200 ...
(A) Scanning electron (SEM) and (B) transmission electron microscopy (TEM) images showing the mVEs (arrowheads) generated on the membrane of L. amazonensis amastigotes. Scale bars: 10 μm (A) and 200 nm (B). A cropped image is presented for best visualization. (C) Nanoparticle tracking analysis (NTA) shows the concentration (particles per ml) and the size (particle size in nm) of L. amazonensis mVEs. Representative image of 2 different mEVs visualized by SEM are shown (inset). (D) The time-lapse release of mEV-TAMRA from L. amazonensis amastigotes in infected BMMs recorded for 60 minutes and examined by confocal microscopy. Representative DIC/TAMRA fluorescence (red) image at 20 minutes of infection. (E) Right images show 4 merged pictures from the time-lapse video recorded for 60 minutes (see Supplemental Video 1). The white arrowhead shows an mVE released by amastigotes. Scale bars: 5 μm (D and E). (F) CD200 levels in BMMs incubated for 1 hour with parasites (L.a), parasite mVEs, or purified mVE-DNA. CpG was used as a positive control to induce CD200 expression. IP-input samples were verified by using actin levels as a loading control, which was used in the densitometric analysis (CD200/actin input ratio).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts